SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VPHM - Viropharma Inc
An SI Board Since December 1998
Posts SubjectMarks Bans Symbol
2557 72 0 VPHM
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2482I am not sure I have any good thoughts on this. It is a big jump in value for Skenhott-9/15/2009
2481Any reason to think Vancocin or OPT-80 wouldn't work equally well? Short courkrw-9/14/2009
2480I assume you have been reading VPHM's communications with the FDA. It is fukenhott-8/10/2009
2479what some of the old crew are up to....... Antimicrob Agents Chemother. 2009 Juscaram(o)uche-8/8/2009
2478I'm sure the fda will bend over backward to give vphm a break after vphm suerkrw-8/7/2009
2477p.s. VPHM claims to have a secret inactive ingredient that impacts drug behaviokenhott-8/7/2009
2476The opportunity for OPT-80 is one that is different than Vanco, at least in theokenhott-8/7/2009
2475What's interesting is through all this c. Diff and Vancocin seem to be on thrkrw-8/6/2009
2474It takes someone with no brain to jump into a no brainer. I found this to be inkenhott-8/6/2009
2473scara... >>Anybody do it? Thanks to you I got interested in VPHM long agIRWIN JAMES FRANKEL-8/5/2009
2472So this is where the dust settles, while vanco continues to sell but erodes withscaram(o)uche-8/5/2009
2471Neither moved very much this morning, maybe because Optimer's Fidaxomicin setnsaf-8/5/2009
2470Akorn was the right trade. If one guessed the panel results, the stock is up 50kenhott-8/5/2009
2469Panel votes against VPHM on bioequivalence issue. ----------------------------- fred hayes-8/4/2009
24684 years from now seems reasonable, probably on the closer end. Take a simplisticrkrw-7/29/2009
2467So the $600M sales milestone might still be 4-5 years away? I know that it is oRocky9-7/29/2009
2466Yep - hope Dr Frank is right and all the steroid users convert in one year. :-)IRWIN JAMES FRANKEL-7/29/2009
2465$80-95M for Cinryze is well above consensus, $55M and $69M (DB and Cowen). Also rkrw-7/29/2009
2464ViroPharma Incorporated Reports Second Quarter 2009 Financial Results - Company IRWIN JAMES FRANKEL-7/29/2009
2463From 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 205IRWIN JAMES FRANKEL-7/15/2009
2462Agreed, implanted port gives patients easier administration, independence with lidos-6/5/2009
2461Some of these people have a port installed which makes the process much easier aIRWIN JAMES FRANKEL16/5/2009
2460Method of administration was and is IV but if a patient had to visit the clinic idos16/5/2009
2459<i>…but I see a bright side in Cinryze's revised label that allows selDewDiligence_on_SI-6/4/2009
2458Bad news on acute, probably means CLS will not be blocked from the market but I idos-6/4/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News